Drug Shortage Report for GABAPENTIN CAPSULES USP

Last updated on 2022-01-15 History
Report ID 152792
Drug Identification Number 02416859
Brand name GABAPENTIN CAPSULES USP
Common or Proper name GABAPENTIN
Company Name ACCORD HEALTHCARE INC
Market Status MARKETED
Active Ingredient(s) GABAPENTIN
Strength(s) 300MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-01-14
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-01-15
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-01-15 English Compare
v2 2022-01-14 French Compare
v1 2022-01-14 English Compare

Showing 1 to 3 of 3